Skip to main content

Table 3 The Blinder–Oaxaca decompose of total testing rate difference between low-income and high-income countries

From: Factors associated with the utilization of diagnostic tools among countries with different income levels during the COVID-19 pandemic

Factors

Difference in characteristics

Percentage (%)

Difference in coefficients

Percentage (%)

Coefficients

95%CI

Coefficients

95%CI

Severity of COVID-19

 Total incident rate

271.22

(224.35 to 318.09)

9.95

169.66

(129.96 to 209.36)

6.22

 Total mortality rate

−76.77

(−125.79 to −27.75)

−2.82

−18.98

(−41.13 to 3.17)

−0.70

Socioeconomic status

 GDP per capita

863.25

(745.01 to 981.49)

31.66

250.81

(159.19 to 342.44)

9.20

 Proportion of age > 70

828.09

(669.10 to 987.09)

30.37

−95.10

(−140.24 to −49.96)

−3.49

Health status

 Cardiovascular diseases

−83.98

(−230.00 to 62.04)

−3.08

46.58

(14.66 to 78.50)

1.71

 Chronic respiratory diseases

25.96

(14.05 to 37.88)

0.95

0.38

(−1.05 to 1.80)

0.01

 Diabetes diseases

44.96

(36.50 to 53.42)

1.65

−1.36

(−2.63 to −0.09)

−0.05

 Neoplasms

−53.13

(−65.57 to −40.69)

−1.95

3.04

(1.54 to 4.53)

0.11

Medical service capacity

 Health workforce density

670.32

(538.49 to 802.14)

24.58

126.11

(67.86 to 184.37)

4.63

Rigidity of response

 Stringency index

3.51

(2.30 to 4.73)

0.13

−0.03

(−0.05 to −0.02)

−0.00

Total differences

2726.59

Explained (due to characteristics)

2493.43 (91.45%)

Unexplained (due to coefficients)

233.15 (8.55%)